Sorrento Therapeutics Inc...
0.00
-0.00 (-100.00%)
At close: Jan 15, 2025, 1:09 PM

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04 FY03
Revenue 62.84M 52.90M 39.99M 31.43M 21.19M 151.86M 8.15M 4.59M 3.83M 460.15K 583.77K 529.18K 682.57K 5.41K n/a n/a n/a n/a n/a n/a
Cost of Revenue 33.45M 13.03M 9.94M 12.24M 10.07M 11.03M 3.70M 1.95M 2.04M 4.44K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit 29.39M 39.87M 30.05M 19.20M 11.12M 140.83M 4.46M 2.64M 1.78M 455.71K 583.77K 529.18K 682.57K 5.41K n/a n/a n/a n/a n/a n/a
Operating Income -504.31M -368.05M -201.53M -195.18M -129.48M 52.34M -59.90M -74.00M -34.74M -21.67M -4.85M -3.24M -1.81M -954.12K -190.51K -240.63K -439.29K -308.03K -763 -763
Interest Income n/a n/a 24.00K 1.09M 921.00K 241.00K 272.00K 24.00K 12.00K 9.62K 7.30K 5.95K 3.79K 11.86K 1.61K 9.00 n/a n/a n/a n/a
Pretax Income -561.75M -462.53M -310.58M -359.58M -213.78M 15.31M -64.83M -13.76M -36.36M -21.91M -4.85M -3.24M -1.81M -942.27K n/a -270.63K n/a -616.06K n/a n/a
Net Income -572.84M -429.01M -308.57M -359.10M -203.54M 9.06M -60.92M -45.81M -34.66M -21.91M -4.85M -3.24M -1.81M -942.27K -188.90K -270.62K -439.29K -308.03K -763 -763
Selling & General & Admin 182.34M 196.86M 116.18M 103.56M 63.64M 32.96M 22.18M 20.13M 9.99M 6.32M 1.61M 1.20M 1.10M 543.95K 190.51K 240.63K 439.29K n/a n/a n/a
Research & Development 221.23M 206.92M 111.34M 106.88M 76.96M 55.53M 42.17M 31.34M 23.98M 9.02M 3.83M 2.57M 1.39M 410.17K n/a n/a n/a n/a n/a n/a
Other Expenses 130.14M 4.14M 4.05M 3.94M 3.01M 2.61M 845.00K 1.16M 2.35M 804.07K n/a n/a n/a n/a n/a n/a n/a -308.03K -763 -763
Operating Expenses 533.70M 407.92M 231.57M 214.38M 140.60M 88.49M 64.35M 52.63M 36.31M 16.14M 5.44M 3.77M 2.49M 954.12K 190.51K 240.63K 439.29K -308.03K -763 -763
Interest Expense 8.57M 10.22M 20.18M 36.14M 57.63M 4.98M 1.61M 1.65M 1.63M 253.19K 7.30K 5.95K 3.79K 11.86K 1.61K n/a n/a n/a n/a 763.00
Selling & Marketing Expenses n/a n/a n/a n/a n/a -5.37M -2.04M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses 567.15M 420.95M 241.51M 226.61M 150.67M 99.52M 68.05M 54.58M 38.36M 16.14M 5.44M 3.77M 2.49M 954.12K 190.51K 240.63K 439.29K -308.03K -763 -763
Income Tax -2.42M -33.52M -2.01M -473.00K -6.27M -36.04M -896.00K 36.31M -1.70M 9.62K 14.60K 11.90K 7.57K 23.71K -1.61K -9 439.29K -308.03K 763.00 763.00
Shares Outstanding (Basic) 419.31M 294.77M 229.82M 140.51M 106.15M 69.74M 50.36M 36.91M 26.68M 15.05M 11.41M 9.92M 8.83M 6.08M 378.02K 257.93K 28.41K 28.41K 28.41K 28.41K
Shares Outstanding (Diluted) 419.31M 294.77M 229.82M 140.51M 106.15M 70.38M 50.36M 36.91M 26.68M 15.05M 11.41M 9.92M 8.83M 6.08M 378.02K 257.93K 28.41K 28.41K 28.41K 28.41K
EPS (Basic) -1.37 -1.46 -1.34 -2.56 -1.92 0.13 -1.21 -1.24 -1.3 -1.46 -0.42 -0.33 -0.2 -0.15 -0.5 -1.05 -15.46 -10.84 -0.03 -0.03
EPS (Diluted) -1.37 -1.46 -1.34 -2.56 -1.92 0.13 -1.21 -1.24 -1.3 -1.46 -0.42 -0.33 -0.2 -0.15 -0.5 -1.05 -15.46 -10.84 -0.03 -0.03
EBITDA -539.93M -435.99M -275.69M -308.39M -147.10M 27.38M -60.34M -9.74M -31.55M -20.37M -4.55M -3.08M -1.78M -939.51K -187.29K -270.62K -439.29K -308.03K -763 -763
Depreciation & Amortization 13.24M 16.32M 14.71M 15.04M 9.05M 7.08M 2.88M 2.37M 3.18M 1.29M 293.30K 159.22K 23.41K 2.75K 3.23K -29.99K n/a n/a n/a n/a

Create Price Alert on SRNE

Your price alert will notify you when the stock price is above 0.00.

Add to Watchlist